Vous avez cherché: immunofluorescence (Anglais - Maltais)

if immunofluorescence
if immunoflorexxenza

immunofluorescence (if) test
it-test ta' l-immunoflorexxenza (if)

demonstration of leptospira in a clinical specimen by immunofluorescence
dimostrazzjoni bl-immunoflorixxenza ta' leptospira f'kampjun klinika

there are several problems inherent to the immunofluorescence test.
hemm bosta problemi inerenti fl-eżaminazzjoni ta’ l-immunoflorexxenti.

demonstration by immunofluorescence of brucella sp. in a clinical specimen
dimostrazzjoni bl-immunoflorixxenza ta' brucella sp. f'kampjun klinika

preparation of samples for gram staining, immunofluorescence staining (if) and eggplant test
preparazzjoni tal-kampjuni għat-tbajja ta’gram staining, tbajjaimmunofluorescence(if) u test tal-brunġiel

a positive immunofluorescence test as specified in annex i or other appropriate positive test has been identified,
test pożittiv ta’ immunofluorescence kif speċifikat fl-anness i jew test xieraq pożittiv ieħor li ġie identifikat,

a negative immunofluorescence test is identified for any sample where morphologically typical fluorescing cells are not found.
test ta’ l-immunoflorexxenti negattiva huwa identifikat għal kwalunkwe kampjun fejn ċelloli morfoloġikament tipikament florexxenti jinstabux.

transient antibodies against leishmania detected by immunofluorescence antibody test (ifat) may appear after vaccination.
wara t-tilqima jistgħu jidhru antikorpi temporanji kontra leishmania li jinkixfu b’test għal antikorpi immunofluworexxenti (ifat).

any remaining extract and additional prepared material for the screening test(s) e.g. immunofluorescence slides, and,
kwalunkwe estratt li jifdal u l-materjal addizzjonali ppreparat għat-test(ijiet) ta' l-iscreening e.g. il-ħġieġa ta' l-immunoflorexxenza, u,

after vaccination transient antibodies against leishmania detected by immunofluorescence antibody test (ifat) may appear but do not reflect an active infection.
wara t-tilqim jistgħu jidhru antikorpi tranżitorji kontra leishmania li jinstabu permezz ta’ test antikorpi immunofluworixxenti (ifat) iżda ma jirriflettux infezzjoni attiva.

samples for which a positive immunofluorescence test have been identified with both antisera shall be considered as 'potentially contaminated' with clavibacter michiganensis ssp. sepedonicus.
kampjuni li għalihom ġie identifikat test pożittiv ta’ immunflorexxenti li fih iż-żewġ antisera għandhom jitqiesu bħala ‘potenzalment imniġġsa’ bil-clavibacter michiganensis ssp. sepedonicus.

confirm that the isolate is an influenza a virus using an immunodoublediffusion test to detect group antigens as described in chapter 9 (immunofluorescence or elisa techniques to detect group antigens may be used if preferred by the national laboratory);
jikkonferma li l-iżolat huwa virus ta' l-influwenza a li juża test ta' diffużjoni rduppjata ta' l-immunità sabiex jiġu skoperti gruppi ta' antiġeni kif deskritti fil-kapitolu 9 (immunoflworessenza jew tekniċi elisa sabiex jinstabu antiġeni fi grupp jistgħu jintużaw jekk dawn huma preferuti mil-laboratorju nazzjonali);

for each suspected occurrence for which a positive immunofluorescence test has been identified according to the method set out in annex i, and confirmation or refutation by completion of the said method is awaited, there should be the retention and appropriate conservation of:
għal kull okkorrenza suspetta li għaliha jiġi identifikat test pożittiv ta’ immunofluorescence skond il-metodu stabbilit fl-anness i, u konferma jew rifjut permezz ta’ twettiq sħiħ ta’ l-istess metodu mistenni, għandu jkun hemm żamma u konservazzjoni xierqa ta’: